These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 9410809)

  • 21. Ovulation induction: a mini review.
    Messinis IE
    Hum Reprod; 2005 Oct; 20(10):2688-97. PubMed ID: 16006478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin modulation of luteinizing hormone secretion in normal female volunteers and lean polycystic ovary syndrome patients.
    Moret M; Stettler R; Rodieux F; Gaillard RC; Waeber G; Wirthner D; Giusti V; Tappy L; Pralong FP
    Neuroendocrinology; 2009; 89(2):131-9. PubMed ID: 18832802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
    Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
    BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Menopause alters the metabolism of serum serotonin precursors and their correlation with gonadotropins and estradiol.
    Carretti N; Florio P; Reis FM; Comai S; Petraglia F; Costa CV
    Climacteric; 2007 Oct; 10(5):393-9. PubMed ID: 17852142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes in molecular forms of sex hormone binding globulin during menstrual cycle and menopause].
    Fonseca ME; Masón M; Ochoa R; Hernández-V M; Zárate A
    Ginecol Obstet Mex; 1996 Nov; 64():508-16. PubMed ID: 9091428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distribution of growth hormone isoforms in sera from women with normal ovarian function, galactorrhea, and normoprolactinemia.
    Ochoa R; Mason M; Fonseca E; Morán C; Zárate A
    Fertil Steril; 1993 Aug; 60(2):272-5. PubMed ID: 8339823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heterogeneity of protein hormones in radioimmunoassay].
    Rosselin G; Bataille D; Laburthe M; Duran-Garcia S
    Pathol Biol (Paris); 1975 Dec; 23(10):793-803. PubMed ID: 57587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Physical, chemical and biologic characterization of human chorionic gonadotropin].
    Schlumberger HD
    Z Naturforsch B; 1968 Nov; 23(11):1412-26. PubMed ID: 4387691
    [No Abstract]   [Full Text] [Related]  

  • 31. [Radioimmunological technics for the determination of gonadotropins].
    Wagner V; Horský J
    Cesk Gynekol; 1970 Apr; 35(3):145-7. PubMed ID: 5444776
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of protein modification in the manufacture of therapeutic and prophylactic preparations].
    Moskvicheva IV; Rutkovskaia VN; Kapitanova NA; Kuznetsova GA; Korotkova TB
    Tr Inst Im Pastera; 1982; 57():126-30. PubMed ID: 7170733
    [No Abstract]   [Full Text] [Related]  

  • 33. LH levels in women with polycystic ovarian syndrome: have modern assays made them irrelevant?
    Milsom SR; Sowter MC; Carter MA; Knox BS; Gunn AJ
    BJOG; 2003 Aug; 110(8):760-4. PubMed ID: 12892688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant gonadotropins.
    Lathi RB; Milki AA
    Curr Womens Health Rep; 2001 Oct; 1(2):157-63. PubMed ID: 12112963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The proportion of molecular forms of gonadotropins changes in patients with polycystic ovaries].
    Mason M; Hernández-Valencia M; Zárate A; Fonseca ME; Ochoa R
    Ginecol Obstet Mex; 1997 Sep; 65():382-5. PubMed ID: 9410809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Variations in the molecular forms of LH and FSH during the normal ovarian cycle].
    Hernandez-Valencia M; Mason M; Eugenia Fonseca M; Zarate A
    Ginecol Obstet Mex; 1996 Mar; 64():140-5. PubMed ID: 8729192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of primary ovarian insufficiency on the molecular heterogeneity of pituitary gonadotropins].
    Mason M; Fonseca ME; Ruiz JE; Morán C; Zárate A
    Ginecol Obstet Mex; 1992 Aug; 60():226-33. PubMed ID: 1398204
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.